Citius Oncology, Inc.

NasdaqCM:CTOR Stock Report

Market Cap: US$70.6m

Citius Oncology Ownership

Who are the major shareholders and have insiders been buying or selling?


Recent Insider Transactions

Insider Trading Volume

Insider Buying: Insufficient data to determine if insiders have bought more shares than they have sold in the past 3 months.


Ownership Breakdown

What is the ownership structure of CTOR?
Owner TypeNumber of SharesOwnership Percentage
Individual Insiders00%
Institutions47,0480.066%
General Public5,207,3867.3%
Public Companies66,049,61592.6%

Dilution of Shares: Shareholders have been substantially diluted in the past year, with total shares outstanding growing by 697.5%.


Top Shareholders

Top 9 shareholders own 92.7% of the company
OwnershipNameSharesCurrent ValueChange %Portfolio %
92.6%
Citius Pharmaceuticals, Inc.
66,049,615US$65.4m0%no data
0.031%
RiverNorth Capital Management, LLC
21,904US$21.7k0%no data
0.022%
Yakira Capital Management, Inc.
15,499US$15.3k0%0.01%
0.0072%
Arbor Point Advisors, LLC
5,130US$5.1k0%no data
0.0033%
Geode Capital Management, LLC
2,332US$2.3k0%no data
0.0023%
UBS Asset Management AG
1,632US$1.6k0%no data
0.00049%
Osaic Wealth, Inc. , Asset Management Arm
350US$345.90%no data
0.00022%
Bank of America Corporation, Asset Management Arm
160US$155.30%no data
0.00006%
Tower Research Capital Europe Limited
41US$42.40%no data